Impact of spin in the abstracts of articles reporting results of randomized controlled trials in the field of cancer: the SPIIN randomized controlled trial.
暂无分享,去创建一个
Sally Hopewell | Douglas G Altman | Isabelle Boutron | Philippe Ravaud | I. Tannock | I. Boutron | D. Altman | P. Ravaud | S. Hopewell | F. Vera-Badillo | Ian Tannock | Francisco Vera-Badillo
[1] Johannes B Reitsma,et al. Overinterpretation and misreporting of diagnostic accuracy studies: evidence of "spin". , 2013, Radiology.
[2] N. Leighl,et al. Shifting patterns in the interpretation of phase III clinical trial outcomes in advanced non-small-cell lung cancer: the bar is dropping. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] J. Ioannidis,et al. Observational studies often make clinical practice recommendations: an empirical evaluation of authors' attitudes. , 2013, Journal of clinical epidemiology.
[4] D. Cescon,et al. Presentation of nonfinal results of randomized controlled trials at major oncology meetings. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] D. Allison,et al. Belief beyond the evidence: using the proposed effect of breakfast on obesity to show 2 practices that distort scientific evidence. , 2013, The American journal of clinical nutrition.
[6] J. Ioannidis,et al. Assessment of claims of improved prediction beyond the Framingham risk score. , 2009, JAMA.
[7] John P A Ioannidis,et al. Overinterpretation of clinical applicability in molecular diagnostic research. , 2009, Clinical chemistry.
[8] C. Booth,et al. Discordance between conclusions stated in the abstract and conclusions in the article: analysis of published randomized controlled trials of systemic therapy in lung cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] I. Tannock,et al. Quality of abstracts describing randomized trials in the proceedings of American Society of Clinical Oncology meetings: guidelines for improved reporting. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Ariel Linden. Identifying spin in health management evaluations. , 2011, Journal of evaluation in clinical practice.
[11] I. Tannock,et al. Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] D. Moher,et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials , 2010, BMJ : British Medical Journal.
[13] P. Armstrong,et al. Transition from meeting abstract to full-length journal article for randomized controlled trials. , 2006, JAMA.
[14] R. Brand,et al. Testing for the presence of positive-outcome bias in peer review: a randomized controlled trial. , 2010, Archives of internal medicine.
[15] Gerd Gigerenzer,et al. Do Physicians Understand Cancer Screening Statistics? A National Survey of Primary Care Physicians in the United States , 2012, Annals of Internal Medicine.
[16] D. Moher,et al. CONSORT for reporting randomised trials in journal and conference abstracts , 2008, The Lancet.
[17] Douglas G Altman,et al. Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. , 2010, JAMA.
[18] E. Loveman,et al. Time to full publication of studies of anti-cancer medicines for breast cancer and the potential for publication bias: a short systematic review. , 2008, Health technology assessment.
[19] Lisa M. Schwartz,et al. Communicating Data About the Benefits and Harms of Treatment , 2011, Annals of Internal Medicine.
[20] Duplicate presentations on prostate cancer at American Urological Association and European Association of Urology annual meetings. , 2009, The Journal of urology.
[21] I. Tannock,et al. The fate of abstracts submitted to a cancer meeting: factors which influence presentation and subsequent publication. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.
[22] R M Pitkin,et al. Accuracy of data in abstracts of published research articles. , 1999, JAMA.
[23] N. Latronico,et al. Quality of reporting of randomized controlled trials published in Intensive Care Medicine from 2001 to 2010 , 2013, Intensive Care Medicine.
[24] M H Ebell,et al. Family physicians' use of medical abstracts to guide decision making: style or substance? , 2001, The Journal of the American Board of Family Practice.
[25] John R. Wilson. Rhetorical strategies used in the reporting of implantable defibrillator primary prevention trials. , 2011, The American journal of cardiology.
[26] Douglas G Altman,et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study , 2008, BMJ : British Medical Journal.
[27] Keiko Kurata,et al. Remarkable Growth of Open Access in the Biomedical Field: Analysis of PubMed Articles from 2006 to 2010 , 2013, PloS one.
[28] Steven Joffe,et al. A randomized study of how physicians interpret research funding disclosures. , 2012, The New England journal of medicine.